|
|
Volumn 96, Issue 2, 2014, Pages 166-168
|
|
The challenge of antimicrobial resistance: New regulatory tools to support product development
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
AREA UNDER THE CURVE;
ARTICLE;
BACTERIAL INFECTION;
CLINICAL TRIAL (TOPIC);
DRUG DEVELOPMENT;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SCREENING;
ECONOMIC ASPECT;
GRAM NEGATIVE BACTERIUM;
HUMAN;
LOGISTIC REGRESSION ANALYSIS;
MINIMUM INHIBITORY CONCENTRATION;
MORBIDITY;
MORTALITY;
NONHUMAN;
PHARMACODYNAMICS;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
|
|
EID: 84904856068
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2014.107 Document Type: Article |
|
Times cited : (19)
|
|
References (4)
|
